Burney Co. Lowers Stock Position in CVS Health Corporation $CVS

Burney Co. trimmed its position in CVS Health Corporation (NYSE:CVS) by 26.2% in the 3rd quarter, HoldingsChannel reports. The fund owned 129,196 shares of the pharmacy operator’s stock after selling 45,923 shares during the quarter. Burney Co.’s holdings in CVS Health were worth $9,740,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the company. Cantor Fitzgerald Investment Advisors L.P. boosted its stake in shares of CVS Health by 1.6% in the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares during the period. Aaron Wealth Advisors LLC lifted its holdings in CVS Health by 177.4% in the 3rd quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after purchasing an additional 21,911 shares in the last quarter. Red Mountain Financial LLC bought a new position in CVS Health in the 2nd quarter worth approximately $293,000. Osaic Holdings Inc. grew its holdings in CVS Health by 18.4% during the 2nd quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock valued at $15,828,000 after buying an additional 35,809 shares in the last quarter. Finally, AE Wealth Management LLC raised its position in shares of CVS Health by 607.5% during the second quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock valued at $16,708,000 after buying an additional 207,984 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on CVS. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Raymond James Financial raised their price objective on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Morgan Stanley boosted their target price on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Barclays raised their price target on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. upped their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $94.67.

CVS Health Trading Up 0.6%

Shares of NYSE CVS opened at $79.60 on Friday. CVS Health Corporation has a 1-year low of $43.65 and a 1-year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The business’s 50 day moving average is $78.91 and its two-hundred day moving average is $72.90. The stock has a market capitalization of $101.04 billion, a P/E ratio of 209.47, a PEG ratio of 0.78 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the previous year, the business earned $1.09 EPS. The company’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.